MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

MDT

87.95

+0.96%↑

A

117.5

+2.09%↑

VEEV

158.5

+4.65%↑

HQY

79.86

+2.23%↑

TLRY

6.73

+2.28%↑

Search

Quidel Corp

Fermé

16.07 15.78

Résumé

Variation du prix de l'action

24h

Actuel

Min

13.56

Max

16.19

Chiffres clés

By Trading Economics

Revenu

602M

-131M

Ventes

24M

724M

Marge bénéficiaire

-18.062

Employés

6,500

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+98.56% upside

Dividendes

By Dow Jones

Prochains Résultats

6 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-193M

1B

Ouverture précédente

0.29

Clôture précédente

16.07

Quidel Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 avr. 2026, 23:25 UTC

Principaux Événements d'Actualité

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy -- Update

13 avr. 2026, 22:45 UTC

Principaux Événements d'Actualité

Westpac Expects Higher Loan Losses as Iran Conflict Slows Australian Economy

13 avr. 2026, 18:03 UTC

Résultats

Louis Vuitton Owner Logs Weak Sales as Middle East War Takes Toll -- 2nd Update

13 avr. 2026, 23:58 UTC

Résultats

Review & Preview: Earnings Time -- Barrons.com

13 avr. 2026, 23:49 UTC

Market Talk

Nikkei May Rise After Overnight Gains on Wall Street -- Market Talk

13 avr. 2026, 23:33 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher Amid Dollar Weakness -- Market Talk

13 avr. 2026, 23:20 UTC

Market Talk

Uranium Stocks Seen Benefiting From Energy Security Concerns -- Market Talk

13 avr. 2026, 23:01 UTC

Résultats

Aura: Capex Guidance Revised From $111M and $130M to New Range of $262M and $314M >AURA33.SA.BR

13 avr. 2026, 23:01 UTC

Résultats

Aura Minerals: Announces Update to Capex Guidance Including Construction of the Era Dorada Project

13 avr. 2026, 23:01 UTC

Résultats

Aura: Will Update Cap Expenditure Guidance to Include the Project's Construction Phase >AURA33.SA.BR

13 avr. 2026, 22:21 UTC

Acquisitions, Fusions, Rachats

Chevron Swaps Offshore Gas Stakes to Boost Venezuelan Heavy-Oil Footprint -- Update

13 avr. 2026, 21:53 UTC

Résultats

MarketWise, Inc.: Affirms FY 2026 Guidance, Including Div Target to Class A Hldrs of $1.80 per Shr

13 avr. 2026, 21:53 UTC

Résultats

MarketWise, Inc.: Paid Subscribers Were 381,000 at March 31 Compared to 374,000 at Dec 31, 2025, Active Free Subscribers Were 2.0M at March 31 >MKTW

13 avr. 2026, 21:53 UTC

Résultats

MarketWise, Inc.: 1Q Billings Increased Approximately 15% Yr-over-Yr to Approximately $81M

13 avr. 2026, 21:53 UTC

Résultats

MarketWise, Inc.: Preliminary Selected Unaudited 1Q Paid Subscribers Returning to Growth

13 avr. 2026, 21:26 UTC

Principaux Événements d'Actualité

U.S. Oil Blockade Is Set to Boost American Exports -- and Prices at the Pump -- WSJ

13 avr. 2026, 21:23 UTC

Résultats

Johnson & Johnson Earnings: Oncology Powers Growth, but Talc Lawsuits Persist -- Barrons.com

13 avr. 2026, 21:16 UTC

Résultats

Goldman Sachs Reports Record Quarter in Banking and Trading -- 4th Update

13 avr. 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Basic Materials Roundup: Market Talk

13 avr. 2026, 20:50 UTC

Market Talk

Auto & Transport Roundup: Market Talk

13 avr. 2026, 20:34 UTC

Résultats

Victory Capital: 1Q Long-Term AUM Net Flows of -$457M >VCTR

13 avr. 2026, 20:34 UTC

Résultats

Victory Capital: March Avg Total AUM Was $315.3B, Avg Other Assets $3.2B, Avg Total Client Assets $318.5B >VCTR

13 avr. 2026, 20:34 UTC

Résultats

Victory Capital Holdings, Inc.: Total Assets Under Management of $309.8B, Other Assets $3.3B, Total Client Assets of $313.1B as of March 31 >VCTR

13 avr. 2026, 19:59 UTC

Market Talk

Canada Consumers Sour Prior to Big Energy-Price Jump -- Market Talk

13 avr. 2026, 19:50 UTC

Market Talk
Principaux Événements d'Actualité

Oil Futures Pull Back From Highs on Hopes for Talks -- Market Talk

13 avr. 2026, 19:27 UTC

Market Talk
Principaux Événements d'Actualité

Correction to Precious Metals Market Talk on April 9

13 avr. 2026, 19:14 UTC

Market Talk

U.S. Natural Gas Futures Settle Lower on Mild Weather -- Market Talk

13 avr. 2026, 18:59 UTC

Market Talk
Principaux Événements d'Actualité

Fed's Goolsbee: Don't Be Surprised If Consumer Confidence Sours -- Market Talk

13 avr. 2026, 18:59 UTC

Market Talk
Principaux Événements d'Actualité

Fed's Goolsbee: Oil Shows People Expect Short Term Conflict in Iran -- Market Talk

13 avr. 2026, 18:43 UTC

Market Talk

Precious Metals Lose Ground as U.S. Blockade in Hormuz Gets Underway -- Market Talk

Comparaison

Variation de prix

Quidel Corp prévision

Objectif de Prix

By TipRanks

98.56% hausse

Prévisions sur 12 Mois

Moyen 27.5 USD  98.56%

Haut 38 USD

Bas 17 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

1

Achat

3

Maintien

1

Vente

Éléments financiers

Frais Généraux et Administratifs

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

Bénéfice d'exploitation

$

À Propos Quidel Corp

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.
help-icon Live chat